United States · FDA National Drug Code directory
Jalyn
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80725-809_bc6c62ea-da7b-4c27-a88e-c80cfcd7856d
- Product NDC
- 80725-809
- Form
- CAPSULE
- Composition / generic term
- DUTASTERIDE and TAMSULOSIN HYDROCHLORIDE
- Labeler
- Waylis Therapeutics
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240301
- Source listing expiry
- 20271231
Source-listed ingredients
- DUTASTERIDE — .5 mg/1
- TAMSULOSIN HYDROCHLORIDE — .4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-13) · 80725-809-13
- 90 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-59) · 80725-809-59
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →